• 1. The First Clinical College of Shanxi Medical University, Taiyuan 030001, P. R. China;
  • 2. Department of Breast Surgery, The First Hospital of Shanxi Medical University, Taiyuan 030001, P. R. China;
WANG Shiming, Email: wangshimingSX@sina.com
Export PDF Favorites Scan Get Citation

Objective To understand the single-cell RNA sequencing (scRNA-seq) and its research progress in the tumor microenvironment (TME) of breast cancer, in order to provide new ideas and directions for the research and treatment of breast cancer. Method The development of scRNA-seq technology and its related research literature in breast cancer TME at home and abroad in recent years was reviewed. Results The scRNA-seq was a quantum technology in high-throughput sequencing of mRNA at the cellular level, and had become a powerful tool for studying cellular heterogeneity when tissue samples were fewer. While capturing rare cell types, it was expected to accurately describe the complex structure of the TME of breast cancer. Conclusions After decades of development, scRNA-seq has been widely used in tumor research. Breast cancer is a malignant tumor with high heterogeneity. The application of scRNA-seq in breast cancer research can better understand its tumor heterogeneity and TME, and then promote development of personalized diagnosis and treatment.

Citation: ZHANG Guangwen, CHENG Chen, WANG Shiming. Single-cell RNA sequencing and its research progress in tumor microenvironment of breast cancer. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2024, 31(4): 495-501. doi: 10.7507/1007-9424.202311050 Copy

  • Previous Article

    Interpretation of the IASLC ninth edition of the TNM classification for lung cancer
  • Next Article

    Transcatheter aortic valve replacement (TAVR) annual report 2023